Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 8207

San Antonio, TX 78258

Study Summary:

A 24 week, mulitcenter, randomised, double-blind, age-stratefied, placebo controlled phase iii study with a 28-week extension period to evaluate the efficacy and safety of dapagliflozin 10 mg once daily in patients with type 2 diabetes, cardiovascular disease and hypertension, who exhibit inadequate glycemic control on usual care

Qualified Participants Must:

• Have type 2 diabetes with high blood pressure
• Be 45 years of age or older if male
• Be 55 years of age or older if female
• Have HbA1c blood level between 7% - 10%
• Be taking at least 2 medications for diabetes and taking something for high blood pressure

Qualified Participants May Receive:

Glucometer device with lancets, strips and medication. Compensation may be provided for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.